MycoBiomDB – Record Details (MyCo_1651)

Biomarker Record Details

Database ID: MyCo_1651
DB IDMyCo_1651
TitleEvaluation of Bronchoalveolar Lavage Fluid Cytokines as Biomarkers for Invasive Pulmonary Aspergillosis in At-Risk Patients
Year2017
PMID29238334
Fungal Diseases involvedInvasive pulmonary aspergillosis
Associated Medical ConditionNone
GenusAspergillus
Speciesfumigatus
OrganismAspergillus fumigatus
Ethical StatementThis study was approved and carried out in accordance with recommendations of the Ethics Subcommittee for Life and Health Sciences of the University of Minho, Portugal, and the Ethics Committee of the University Hospitals of Leuven, Belgium.
Site of InfectionNone
Opportunistic invasiveInvasive/Opportunistic
Sample typeBody fluid
Sample sourceSerum
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameIL-17A
Biomarker Full NameInterleukin-17A
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationMulti-Location
Cohort48 patients with IA and 48 matched controls were available and analyzed for cytokine levels.
Cohort No.48 Patients and 48 control
Age GroupNone
P ValueNone
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismInvasive pulmonary aspergillosis (IPA) is a life-threatening infection caused predominantly by the opportunistic fungus Aspergillusfumigatus. It is commonly diagnosed among patient with immunological deficits, namely those with hematologic malignancies during chemotherapy or undergoing solid organ or allogeneic hematopoietic cell transplantation.
TechniqueELISA
Analysis MethodELISA Based
ELISA kitsELISA Kit- Platelia Aspergillus (Platelia Aspergillus EIA; Bio-Rad, Marnes la Coquette, France), Human Premixed Multi-Analyte Kits (R&D Systems, MN, USA).
Assay DataNone
Validation Techniques usedELISA
Up Regulation Down RegulationIncrease
Sequence DataNone
External LinkNone